Other
Journal
About P&T Journal
Contacts:Editor:
ssherritze@medimedia.com
Advertising:
mliberti@medimedia.com
Circulation:
lgardineer@medimedia.com
Production:
wpeart@medimedia.com
Rate Card
Production Specifications
Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints
Recent Issues
April 2012
Features
Health Care and Law
Impact of Federal and State Legal Trends on Health Care Services
Legal and policy changes implemented by the government affect all health care professionals, pharmacies, and insurers. The authors examine the signing of the Affordable Care Act (ACA), the hearings on the constitutionality of the ACA, and congressional efforts to reduce the nation’s health care–related deficits.
E. Paul Larrat, RPh, PhD; Rita M. Marcoux, RPh, MBA; and F. Randy Vogenberg, RPh, PhD
Pruritus in the Elderly
Clinical Approaches to the Improvement of Quality of Life
Pruritus is the most common skin disorder in elderly patients. The many causes of chronic itching, as well as topical, systemic, and nonpharmacological therapies, are reviewed.
Kenneth R. Cohen, PharmD, PhD; Jerry Frank, MD; Rebecca L. Salbu, PharmD, CGP; and Igor Israel, MD
Lupus: An Overview of the Disease and Management Options
As a chronic inflammatory autoimmune disease, lupus affects many organ systems. The physiology, causes, types, diagnostic challenges, and treatments are discussed, with an emphasis on systemic lupus erythematosus.
William Maidhof, PharmD; and Olga Hilas, PharmD, MPH, BCPS, CGP
Meeting Highlights
2012 Integrative Healthcare Symposium
Treating the Pain of Lyme Disease and Adopting Lifestyle Change as Therapy
Topics include therapies for chronic Lyme disease, the new "great imitator," and Dr. Dean Ornish’s claim that modifications in lifestyle may enable patients to reverse coronary atherosclerosis without drugs or surgery.
Walter Alexander
Departments
Medication Errors
Color-Coded Syringes for Anesthesia Drugs — Use With Care
Labels on color-coded syringes for anesthetics must be read carefully.
Matthew Grissinger, RPh, FASCP
Prescription: Washington
National Plan for Alzheimer’s Disease Aims to Jump-Start Drug Development
Federal Funding Levels Remain Uncertain
The Obama administration's draft plan for Alzheimer's disease includes urgently needed funding and an expansion of clinical trials.
Stephen Barlas
New Drugs/Drug News/New Medical Devices
FDA approvals, drug indications, and updates
Pharmaceutical Approval Update
Ivacaftor (Kalydeco) tablets for cystic fibrosis; vismodegib (Erivedge) for metastatic basal cell carcinoma; and linagliptin/ metformin tablets (Jenta-dueto)
Marvin M. Goldenberg, PhD, RPh, MS
Belimumab (Benlysta)
A Breakthrough Therapy for Systemic Lupus Erythematosus
Belimumab (Benlysta) for systemic lupus erythematosus
Raymond Lamore III, PharmD; Sapna Parmar, PharmD; Khilna Patel, PharmD Candidate; and Olga Hilas, PharmD, MPH, BCPS, CGP
